中华耳鼻咽喉头颈外科杂志
中華耳鼻嚥喉頭頸外科雜誌
중화이비인후두경외과잡지
CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY
2014年
6期
479-482
,共4页
李丽娟%温树信%王斌全%高伟%张文%孟晓敏%杨丽娟%孔令帅
李麗娟%溫樹信%王斌全%高偉%張文%孟曉敏%楊麗娟%孔令帥
리려연%온수신%왕빈전%고위%장문%맹효민%양려연%공령수
肿瘤干细胞%硫酯水解酶类%喉肿瘤%癌,鳞状细胞%预后
腫瘤榦細胞%硫酯水解酶類%喉腫瘤%癌,鱗狀細胞%預後
종류간세포%류지수해매류%후종류%암,린상세포%예후
Neoplastic stem cells%Thiolester hydrolases%Laryngeal neoplasms%Carcinoma,squamous cell%Prognosis
目的 探讨肿瘤干细胞标记物泛素特异性肽酶22(USP22)蛋白在喉鳞状细胞癌(鳞癌)中的表达水平及其与临床分期、分化程度、淋巴转移及预后等临床病理参数的关系.方法 用免疫组化法检测USP22蛋白在64例喉鳞癌组织和26例正常喉黏膜(对照组)组织中的表达,分析其与临床病理学特征的关系.Kaplan-Meier法与Log-rank检验分析生存情况.结果 USP22蛋白在喉鳞癌组和对照组的阳性表达率分别为57.8%和19.2% (P <0.05),其表达分别在不同的临床分期、T分期及淋巴转移之间差异有统计学意义(P值均<0.05),而在性别、年龄、吸烟、分化程度及分型之间差异无统计学意义(P值均>0.05);生存分析结果显示喉癌患者USP22蛋白高表达比USP22低表达的预后差;不同分型的5年生存率由高到低的顺序是声门型、声门上型、声门下型.单因素临床分期、T分期、淋巴结是否转移、分化程度对预后的影响有统计学意义(P值均<0.05),而年龄、性别、吸烟与患者的预后无关(P值均>0.05).结论 USP22蛋白在喉鳞癌组织中表达明显增高,其高表达与喉鳞癌的恶性程度、侵袭转移及预后有关.USP22蛋白可能是一个新的候选喉癌干细胞标志物和治疗的靶点.
目的 探討腫瘤榦細胞標記物汎素特異性肽酶22(USP22)蛋白在喉鱗狀細胞癌(鱗癌)中的錶達水平及其與臨床分期、分化程度、淋巴轉移及預後等臨床病理參數的關繫.方法 用免疫組化法檢測USP22蛋白在64例喉鱗癌組織和26例正常喉黏膜(對照組)組織中的錶達,分析其與臨床病理學特徵的關繫.Kaplan-Meier法與Log-rank檢驗分析生存情況.結果 USP22蛋白在喉鱗癌組和對照組的暘性錶達率分彆為57.8%和19.2% (P <0.05),其錶達分彆在不同的臨床分期、T分期及淋巴轉移之間差異有統計學意義(P值均<0.05),而在性彆、年齡、吸煙、分化程度及分型之間差異無統計學意義(P值均>0.05);生存分析結果顯示喉癌患者USP22蛋白高錶達比USP22低錶達的預後差;不同分型的5年生存率由高到低的順序是聲門型、聲門上型、聲門下型.單因素臨床分期、T分期、淋巴結是否轉移、分化程度對預後的影響有統計學意義(P值均<0.05),而年齡、性彆、吸煙與患者的預後無關(P值均>0.05).結論 USP22蛋白在喉鱗癌組織中錶達明顯增高,其高錶達與喉鱗癌的噁性程度、侵襲轉移及預後有關.USP22蛋白可能是一箇新的候選喉癌榦細胞標誌物和治療的靶點.
목적 탐토종류간세포표기물범소특이성태매22(USP22)단백재후린상세포암(린암)중적표체수평급기여림상분기、분화정도、림파전이급예후등림상병리삼수적관계.방법 용면역조화법검측USP22단백재64례후린암조직화26례정상후점막(대조조)조직중적표체,분석기여림상병이학특정적관계.Kaplan-Meier법여Log-rank검험분석생존정황.결과 USP22단백재후린암조화대조조적양성표체솔분별위57.8%화19.2% (P <0.05),기표체분별재불동적림상분기、T분기급림파전이지간차이유통계학의의(P치균<0.05),이재성별、년령、흡연、분화정도급분형지간차이무통계학의의(P치균>0.05);생존분석결과현시후암환자USP22단백고표체비USP22저표체적예후차;불동분형적5년생존솔유고도저적순서시성문형、성문상형、성문하형.단인소림상분기、T분기、림파결시부전이、분화정도대예후적영향유통계학의의(P치균<0.05),이년령、성별、흡연여환자적예후무관(P치균>0.05).결론 USP22단백재후린암조직중표체명현증고,기고표체여후린암적악성정도、침습전이급예후유관.USP22단백가능시일개신적후선후암간세포표지물화치료적파점.
Objective To investigate the expression of cancer stem cell marker USP22 in laryngeal squamous cell carcinoma (LSCC) and clinical implications.Methods The expression of USP22 was detected by immunohistochemistry in LSCC tissues of 64 cases and squamous epithelium tissues beside carcinoma of 26 cases (control).The correlation of USP22 expression with various clinicopathologic factors was evaluated with the single factor analysis.Results The expression levels of USP22 in LSCC and control were 57.8% and 19.2% (P < 0.05).Clinicopathological analysis showed that USP22 expression level had a relationship with clinical stage,T stage,and lymph node metastasis(P < 0.05),but not with gender,age,smoking and differentiation(P > 0.05).Survival analysis showed that patients with high USP22 expression had significantly poorer outcome compared with patients with low USP22 expression.The survival was related to clinical stage,T stage,and lymph node metastasis,but not with age,sex,and smoking (P > 0.05).Conclusions The expression of USP22 is significantly increased in LSCC,which correlates with the malignant degree,invasion,metastasis and prognosis of LSCC.USP22 may be served as a new candidate molecular marker and therapeutic target of LSCC.